MRMD News and Press, MariMed Inc From 11/08/22

MariMed Inc. (MRMD) Q3 2022 Earnings Conference Call November 08, 2022 8:00 AM ET Company Participants Steve West – Vice President-Investor Relations Bob Fireman – Chief Executive Officer Jon Levine – President Tim Shaw – Chief Ope...

The following slide deck was published by MariMed Inc. in conjunction with their 2022 Q3 earnings call. For further details see: MariMed Inc. 2022 Q3 - Results - Earnings Call Presentation

MariMed press release ( OTCQX:MRMD ): Q3 GAAP EPS of $0.01. Revenue of $33.91M (+2.1% Y/Y) misses by $0.69M . Gross margin of 48% vs. 55% in a year ago quarter. FY 2022 Guidance: Revenue of $132 million to $135 million. Gross margin of 48% to 49%. Non-...

NORWOOD, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the third quart...

MariMed ( OTCQX:MRMD ) is scheduled to announce Q3 earnings results on Monday, November 7th, after market close. The consensus EPS Estimate is $0.01 and the consensus Revenue Estimate is $34.6M Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 do...

Best Cannabis Stocks To Watch Next Month As the market falls, are you looking for the top marijuana stocks ? Trading cannabis penny stocks is one method cannabis investors are leveraging the present expansion of the cannabis industry. For the ease of those who are unsure, any stock ...

NORWOOD, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc (CSE: MRMD), (OTCQX: MRMD), (“MariMed” or the “Company”) today announced the evolution of its top-selling Betty’s Eddies all-natural cannabis fruit chews brand to help cannabis cons...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips For all the cannabis sector’s promise and growth potential, not much has stirred it market-wise apart from a, shall we say, blunt drop. But, today, I have three bullish cannabis stock predictions for the upcoming yea...

Summary MariMed is priced like the company is going out of business. The small MSO is building a corporate structure for up to $500 million in annual sales. The stock has a minimal market cap of only $250 million while revenues will top $150 million next year on the opening of...

NORWOOD, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its third quarter 2022 finan...